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ABSTRACT 
<^'' 
Amphiphiles are molecules containing two parts with different properties 
concerning lyophilicity, preference for a solvent. Usually molecules conisting 
of one water preferring part, hydrophilic, and one oil preferring or water fearing 
part, referred to as lipophilic or hydrophobic, are called amphiphiles. The 
hydrophobic part of the amphiphilic molecules usually consists of one or two 
hydrocarbon chains whereas the hydrophilic part can be ionic or contain 
uncharged polar groups. 
Amphiphilic systems are important to a number of chemical processes 
ranging from the existence of lipid bilayers to the use of detergents in industrial 
and home applications. The single feature of amphiphiles that gives rise to such 
broad utility is their ability to coexist with and function as an interface between 
polar and nonpolar phases. This ability is determined by a balance between 
ionic and dipolar interactions with polar media and dispersion interactions with 
nonpolar media. Micelles are a subset of amphiphilic systems that manifest 
transient self-assembly behaviour in certain concentration regimes, and this 
family of solution-phase aggregates has been studied extensively. 
Solutes showing hydrophobic self-association may be classified into four 
categories on the basis of the chemical structure: (A) flexible chain compounds 
(surfactants, etc.), (B) aromatic or heterocyclic ring or fused ring structures 
(dyes, drugs, etc.), (C) alicyclic fused ring compounds (bile salts, etc.), and (D) 
macromolecular solutes (proteins, etc.). The self-association behaviour must 
relate to the chemical structure of the solutes. 
SURFace ACTive AgeNTS or surfactants owe their name to their 
interesting behaviour at surfaces and interfaces. Being surface active means 
that these molecules adsorb at the interface between two bulk phases, such as 
gas/liquid, liquid/liquid, or solid/liquid. Schemes for classifying surfactants are 
typically based on physical properties or functionality. The most prevalent 
physical property used in classification is ionicity: anionic, cationic, nonionic 
and zwitterionic surfactants. 
Among the factors known to affect self-association behaviour markedly 
in aqueous solutions are: (i) structure of the amphiphiles, (ii) presence of 
various additives in the solution, (iii) experimental conditions such as 
temperature, pH, pressure, solvent, etc. 
A large number of drug molecules are amphiphilic and self-associate in 
aqueous environment. According to definition of the World Health 
Organization, a drug is any substance or product that is used to modify or 
explore physiological systems or pathological states for the benefit of the 
recipient.^ In the context of medicine, it means a chemical used in the 
prevention, diagnosis or treatment of diseases. 
Drugs are regarded as biologically active chemical compounds mostly 
with a therapeutic purpose which can be broadly classified into: 
I. Biological classification 
II. Chemical classification 
III. Classification of drugs according to commercial consideration 
IV. Classification by the lay public 
When two neat liquids are brought together, they may either mix into a 
homogeneous solution or they may form two solutions, where in each case one 
of the components can be regarded as the solvent. Normally in the latter case, 
the compositions of the two phases in equilibrium become more equal when the 
temperature is increased. There are, however, frequent exceptions from this 
expected behaviour. Such systems are represented by liquids that are completely 
miscible at low temperatures but phase separate when heated. This is observed 
by the clear solution present at low temperatures suddenly becoming cloudy on 
heating. The temperature where this occurs is referred to as the cloud point 
(CP). 
It is well known that CP is a common property of many aqueous 
nonionic surfactant solutions.^'^ Below CP, a single phase of molecular or 
micellar solution exists, above it water solubility of surfactant is reduced and a 
cloudy dispersion results by the formation of giant molecular aggregates in the 
state of separate phase.^'^ Water soluble polymers also exhibit clouding by a 
similar mechanism. The phenomenon is reversible and the CP stands for 
transition from water-soluble state to oil-soluble state. ^  
Generally, the clouding behaviour would not happen in ionic surfactant 
systems because of significant electrostatic repulsions between the charged 
aggregates. Nevertheless, previous researches showed that aqueous solutions of 
some ionic surfactants with high salt concentration,^ salt free aqueous solutions 
of certain ionic surfactants with large head groups,'° or large countedons, and 
some mixed cationic and anionic surfactant solutions"''^ also exhibited the 
above behaviour. The mechanism of the behaviour in these ionic surfactant 
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solutions is still an open question. ' 
Recently, Kim and Shah''* have observed the CP phenomenon in 
amphiphilic drug amitriptyline hydrochloride (AMT) solutions and have 
explored the effect of additves. 
When using drugs it should be kept in mind that normal human body 
temperature is typically 12 degrees above ambient. Even if the CP of pure drug 
in buffer is above this temperature, it may decrease in presence of additives, 
especially surfactants which are used as drug carriers. As clouding concentrates 
the drug in a small volume, it may affect the activity of drugs and, therefore, it 
is important to have knowledge of clouding behaviour of these drugs in 
designing more effective drug-carrier combinations. With this idea in mind, 
effect of various additives, viz., electrolytes, non-electrolytes, alcohols, amino 
acids, sugars, polymers, surfactants, and their concentration effects have been 
examined on the CP behaviour of some amphiphilic drugs. 
Chapter I is General Introduction wherein details of the behaviour of 
amphiphiles (surfactants, drugs, etc.), various phenomenona exhibited by them, 
and the effect of additives are described. An up-to-date literature survey related 
to the work embodied in subsequent chapters is also included. 
Chapter II deals with the Experimental details which have been 
followed in the study. Materials used, individual purity, make, etc. are also 
included in tabular form. 
Chapter III contains cmc data for two antidepressant (AMT and IMP) 
and two phenothiazine (CPZ and PMT) drugs in aqueous media. In this surface 
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Scheme 1: Molecular structure of amphiphilic drugs. 
properties (in water and in presence of varying concentrations of NaCl, CTAB 
and TX-lOO) of the four amphiphilic drugs are presented. The parameters 
evaluated are cmc (critical micelle concentration), /"^ax (maximum surface 
excess concentration at air/water interface) and Am\n (minimum area per 
surfactant molecule at the air/water interface). Fmax increases and cmc/^ min 
decreases with increasing concentration of the additives. The cmc values 
obtained by dye solubilization method for the systems follow the same trend. 
The behaviour is explained on the basis of mixed micelle formation and 
counterion adsorption. 
Studies on the effect of various additives on the CP values of the two 
antidepressant and two phenothiazine drugs are described in Chapter IV. The 
CPs of 50 mM drug (for IMP, 100 mM) solutions (prepared in 10 mM sodium 
phosphate, SP, buffer) were found to decrease with increasing pH, both in the 
absence as well as presence of additives (NaCl, NaBr, NH4Br, CTAB, 
arabinose, C60H). The CP decrease with the increase in pH is due to 
deprotonation of tertiary amine portion of the drug molecules (Scheme 1). The 
deprotonation increases intermicellar compactness due to decrease in head 
group repulsion, which leads to decrease in CP. Addition of increasing amounts 
of salts (NaT, NaCl, NaBr, LiBr, KBr, NH4Br) to 50 mM drug (for IMP, 100 
mM) solutions (at pH 6.7) caused continuous increase in CP. On the basis of 
these studies the binding-effect orders of counterions and colons have been 
deduced, respectively, as: Br' > CI' > F' and Li '*" < Na'*^  < K"*^  < NH "^^ . The 
similar trend of increasing CP with addition of increasing amounts of 
quaternary ammonium bromides (TMeAB, TEtAB, TPrAB, TBuAB, TPeAB) 
to 50 mM drug (for IMP, 100 mM) solutions (at pH 6.7) was found to be 
dependent upon the alkyl chain length of the particular salt. 
Tetraalkylammonium ions are water- structure formers and this effect increases 
with increase in the length of the alkyl group. The CP rising in the case of QA"^  
cations is ascribed to adsorption/mixed micelle formation predominating over 
water-structure formation. In such cases, micelles would experience greater 
intemiicellar repulsions and consequently higher CPs. 
Urea and alkylureas decreased the CP, and the effect was found to be 
dependent upon the number of methyl groups present in the urea molecules. 
Contrary to this, thioureas increased the CP slightly (only in case of 
antidepressants). However, the presence of methyl group(s) has similar effect 
as in alkylureas. Urea is known to replace water molecules from the head group 
region;'^ therefore, CP decreases with urea addition. Rate of decrease in CP 
increases as the number of methyl groups increases in urea. Inclusion of mono-, di-
and tetramethyl groups in urea increases the size of alkyl ureas and, therefore, more 
water is replaced by their addition with the result that the CP decrease becomes 
progressively more pronounced, i.e., TMU>DMU>MMU. Effect of adding thioureas 
on the CP of the drugs is interesting — it's opposite to what has been observed with 
ureas in case of AMT and IMP but same in case of CPZ and PMT. The opposite effect 
of thiourea may be due to the difference in the nature of bonds: the >C=0 is stronger 
than >C=S as O is more electronegative. Therefore, electrons around S atom will be 
delocalized, thus making the S-atom electron deficient, i.e., a Lewis acid. As a result, 
the S-atom in thiourea would behave like a positive center and repulsion between 
thiourea and drug micelle (a cationic center) could be responsible for the observed CP 
increase. However, with phenothiazines, CP decrease may be due to presence of a S-
atom in the drug molecules. 
All the sugars caused a decrease in CP of all the four drugs. Sugars are known 
as water-structure makers and enhance the association of water molecules by 
hydrogen bonds. Thus, sugars decrease the availability of water to the head groups 
and lower the CP. 
Effect of amino acids on the CP of the drug solutions depended upon their 
acidic/basic as well as polar/nonpolar characteristics. The effect may be explained 
on the basis of taking cognizance of polarity and hydrophobicity. In case of 
acidic amino acids (DL-aspartic and glutamic), the acidic group would interact 
with the tertiary amine of drug allowing entry of water and resulting in more 
hydrated micelles; this leads to increase in the CP. On the other hand, 
hydrophobic nonpolar and uncharged polar amino acids would prefer either the 
micelle interior or bulk water and in doing so they would not affect the 
hydration of micelles. Therefore, this category of the amino acids would not 
affect CP much. The basic amino acids (L-lysine, L-arginine and L-histidine) prefer a 
polar environment, and thus they would partition in the head group region with the 
observance of CP phenomenon at a lower temperature. In case of hydrochloride salt 
additions, however, a positive charge would be imparted to drug micelles with a 
concomitant repulsion among the aggregates and an increase in CP is observed. 
The CP remained constant with lower alcohols (Ci - C4OH), but higher ones 
(C7OH, CgOH, due to their hydrophobic nature) decreased it while medium chain 
alcohols (C5OH, CeOH) showed peaked behaviour (except with PMT). With diols, the 
CP remained constant but showed peaked behaviour with cycloalkanols (except with 
PMT). Short chain alcohols are hydrophilic in nature and due to favourable 
interactions with water these alcohols modify the water structure, making it more 
compatible with the single surfactant molecules. Hence CP remains nearly constant. 
Medium chain alcohols, at high concentrations, also solubilize in palisade layer and 
decrease the CP. Longer chain alcohols are hydrophobic but, due to -OH group, 
solubilize in head group region. Therefore, larger aggregates would form and 
CP decreases. 
Diols, being highly miscible in water and hydrophilic (as they contains 
two -OH groups on hydrophilic ethane or propane molecules), remain in 
aqueous phase at all concentrations and would not affect the micelle hydration. 
However, cycioalkanols show different behaviour; with cyclopentanol, CP 
decreases from the start while with cyclohexanol it shows a peaked behaviour, 
which becomes more pronounced with ally! alcohol. Cyclopentanol is sparingly 
soluble in water while cyclohexanol is slightly soluble (3.6%w/w). This shows 
that cyclopentanol is more hydrophobic than cyclohexanol. Therefore, 
cyclopentanol solubilizes in the micelles, which is evident from the decrease in 
CP from the start. Cyclohexanol, after 100 mM (except PMT), starts 
solubilizing in the micelles. Allyl alcohol is completely miscible with water. 
The decrease in CP in its presence can be explained in the light of its effect on 
solvent structure. It promotes the water-structure, thereby decreasing the 
availability of water to the micelles. 
Surfactants/polymers are used extensively in drug delivery as drug 
carriers. At fixed [drug] (50 mM, in case of IMP 100 mM for cationic and 
nonionic and 150 mM for anionic) and pH (6.7) surfactants and polymers affect 
the CP in accordance to their nature and structure: anionic surfactants show an 
increase followed by a decrease, whereas cationic (conventional as well as 
gemini) and non-ionic surfactants show continuous increase. 
11 
At low concentrations, the anionic surfactant molecules adsorb at the 
micellar interface and inhibit micellization resulting in an increase in CP. At 
higher concentrations, the added surfactant increases the compactness of the 
micelles and leads to micellar growth. Intercalation of anions into the drug 
micelles would reduce the head group repulsions and enhance the hydrophobic 
interactions and would reduce the minimum head group area per monomer (Oo) 
and increase the volume of hydrocarbon part of the monomer (v). Therefore, 
the Mitchell-Ninham parameter, Rp (= VIGOIQ), increases. Added cationic 
surfactants exist in the drug solutions as monomers, micelles and mixed 
micelles depending on their cmc values. If the surfactant is in monomeric form, 
it would form mixed micelles while cationic micelles of the surfactant would 
exist if the [surfactant] is above cmc. Both cases increase the inter-aggregate 
repulsion with an increase in the CP of the drug solutions. The nonionic 
surfactants possess hydrophilic oxyethylene chains and mixed micelles of drug-
surfactants would be highly hydrated. Hence CP increases. 
The behaviour with polymers is dictated by the number of units present in a 
particular polymer. 
Increase in drug concentration in presence of fixed amounts of additives 
(NaBr, arabinose, CeOH, CTAB) increases the CP. Increase in drug 
concentration increases the number of micelles. Therefore, repulsions in the 
solution increase due to increase in size and charge of the micelles, resulting in 
an increase in CP. 
12 
Variation of CP with pH at various fixed 16-6-16 gemini concentrations 
shows that gemini surfactants may be better candidates for drug delivery. 
Decrease in CP with the increase in pH indicates that the deprotonation of the 
drug is more at higher pHs, which lowers the CP. 
Overall the electrolytes, none lee trolytes and surfactants have a large 
amount of effect on CP of amphiphilic drugs, because of their 
hydrophilicity/hydrophobicity, effect on water-structure, mixed micelle 
formation, etc. 
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Chapter-I 
General Introduction 
Amphiphiles are molecules containing two parts with different properties 
concerning lyophilicity - preference for a solvent. Usually molecules consisting 
of one water preferring part, hydrophilic, and one oil preferring or water fearing 
part, referred to as lipophilic or hydrophobic, are called amphiphiles. The 
hydrophobic part of the surfactant molecules usually consists of one or two 
hydrocarbon chains whereas the hydrophilic part can be ionic or contain 
uncharged polar groups. 
Amphiphilic systems are important to a number of chemical processes 
ranging from the existence of lipid bilayers to the use of detergents in industrial 
and home applications. The single feature of amphiphiles that gives rise to such 
broad utility is their ability to coexist with and function as an interface between 
polar and non-polar phases. This ability is determined by a balance between 
ionic and dipolar interactions with polar media and dispersion interactions with 
non-polar media. Micelles are a subset of amphiphilic systems that manifest 
transient self-assembly behaviour in certain concentration regimes, and this 
family of solution-phase aggregates has been studied extensively. 
Dispersed in water, these amphiphiles form different types of aggregates 
in which the hydrophobic moieties are shielded from water, the solvated 
hydrophilic groups being located at the surface of aggregate.'''^ The self-
association gives rise to a rich variety of phase structures (Fig. 1.1). The state of 
aggregation of amphiphiles in an aqueous solution is a complex function of their 
structure, the charge of molecules, and the aqueous solvent properties 
(concentration of the amphiphile, ionic strength, pH, temperature, etc.). 
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Aggregation is not, however, just limited to aqueous solutions; it is sometimes 
observed in non-aqueous polar solvents such as ethylene glycol and non-polar 
solvents such as hexane (in the latter case giving rise to inverse structures). 
Surfactants with aliphatic chains generally aggregate to micelles with 
aggregation numbers between 40 and 200, depending on their particular 
molecular structure.'' 
Solutes showing hydrophobic self-association may be classified into four 
categories on the basis of the chemical structure: (A) flexible chain compounds 
(surfactants, etc.), (B) aromatic or heterocyclic ring or fused ring structures 
(dyes, drugs, etc.), (C) alicyclic fused ring compounds (bile salts, etc.), and (D) 
macromolecular solutes (proteins, etc.).^ The self-association behaviour must 
relate to the chemical structure of the solutes. The simplest type of association, 
viz., dimerization, may take place in all the self-associating systems being 
considered. The formation of higher multimers may overshadow it, however, 
more or less completely.^ 
(A) Surfactants and Their Classification 
SURFace ACTive AgeNTS or surfactants owe their name to their 
interesting behaviour at surfaces and interfaces. Being surface active means that 
these molecules adsorb at the interface between two bulk phases, such as 
gas/liquid, liquid/liquid, or solid/liquid. Here interface indicates a boundary 
between any two immiscible phases and the term surface denotes an interface 
where one phase is gas, usually air. They are vital components in biological 
systems,^'^ form key ingredients in consumer products and play an important 
role in many industrial processes. 
Many types of substances act as surfactants, but all share the property of 
amphipathy: the molecule is composed of a non-polar hydrophobic portion and 
a polar hydrophilic portion and is, therefore, partly hydrophilic and partly 
hydrophobic. Surfactants may be referred to as either amphiphilic or 
amphipathic; the terms are synonymous. 
Schemes for classifying surfactants are typically based on physical 
properties or functionality. The most prevalent physical property used in 
classification is ionicity: is surfactant charged or uncharged, ionic or nonionic? 
Surfactant is characterized as ionic if on dissolution in water the surface-active 
portion containing the hydrophobic chain has net charge. The ionic surfactants 
are further classified as cationic and anionic depending on whether the head 
group is positively or negatively charged. 
(i) Cationic surfactants 
The most prevalent cationic surfactants are based on quaternary 
nitrogen. Alkylammonium halides and tetra-alkylammonium halides are the 
most numerous in this class. Examples: 
CH3(CH2)i3N (CH3)3Br (tetradecyltrimethylammonium bromide) 
CH3(CH2)i5N C6H5CI (cetylpyridinium chloride) 
(ii) Anionic surfactants 
Alkali alkanoates are the most well known anionic surfactants. These 
include the traditional soaps (—C02~) and the early synthetic detergents, the 
sulphonates (-SO3 ) and sulphates (-OSO3 ). Examples: 
CH3(CH2),oCOO'Na^ (sodium laurate) 
CH3(CH2)iiC6H4S03T^a"^ (sodium dodecylbenzenesulphonate) 
(Hi) Nonionic surfactants 
As their name implies, nonionic surfactants contain only electrically 
neutral head groups. These are dominated by the ethoxylates, - ( -
OCH2CH2)nOH. This class of surfactants also includes several so-called semi-
polar compounds such as the amine oxides, sulphoxides, phosphine oxides, 
pyrrolidones, and sugars. Examples: 
C8Hi7C6H40(CH2CH20)nH (polyoxyethylene /-octylphenyl ether) 
CH3(CH2),30(OCH2CH2)nH (polyoxyethylene tetradecyl ether) 
(iv) Zwitterionic surfactants 
The combination of just about any anionic and cationic group in a single 
amphiphilic molecule confers amphoteric character and is taken to constitute a 
zwitterionic surfactant. This type of surfactants can behave as either an anionic, 
nonionic or cationic species depending on the pH of the solution. Examples: 
CH3(CH2)9N^(CH3)2CH2C02~ (yV-decyl-MTV-dimethyl betaine) 
CH3(CH2)iiN'^ (CH3)2(CH2)3S03" (3-dimethyldodecylammonio)propane-l-sulphonate) 
(v) Gemini surfactants 
Recently, a new class of surfactant has been introduced. ' These 
surfactants, in contrast to their more conventional (one alkyl chain and one head 
group) counterparts, are made of two hydrophobic chains and two hydrophilic 
head groups covalently attached through a spacer group which can be 
hydrophobic or hydrophilic, flexible or rigid.^ These are known as dimeric or 
gemini and few of them possess remarkable rheological properties 
(viscoelasticity, gelification, shear thickening) at relatively low concentration, 
which are not observed with conventional surfactants having the same alkyl 
chain.'' 
Examples: 
(CH3)2N-(CH2)4—N(CH3)2 2 Br 
I I 
C,6H33 C,6H33 
(butanediyl-a, co-bis(A^-hexadecyl-A/,A'-dimethylammonium bromide)) 
"O2CH2CNCOH31C, 5-(CH2)4-C, 5H31CONCH2CO2" 2Na^ 
(pentadecyl-a, ft>-bis(sodium-A''-butyl-y9-alaninate)) 
One of the most characteristic properties of amphiphilic molecules is 
their capacity to aggregate in solutions. The aggregation process depends, of 
course, on the amphiphilic species and the condition of the system in which 
they are dissolved. The abrupt change in many physicochemical properties seen 
in aqueous solutions of amphiphilic molecules or surfactants with long 
hydrophobic chains when a specific concentration is exceeded is attributed to 
the formation of oriented colloidal aggregates. The narrow concentration range 
over which these changes occur has been called the critical micelle 
concentration (cmc),'^"^^ and the molecular aggregates that form above the cmc 
area are known as micelles. The difference between micellar colloids and other 
colloids is micellar colloids are in dynamic equilibrium with monomers in the 
solution. 
The micellar aggregation can be demonstrated by measuring solution 
properties, such as surface tension,'^'"^'' dye solubilization, '^ water 
solubilization,^^ 'H-NMR,^^"^*^ light scattering, '^" '^^  fluorimetry,^^''" osmotic 
pressure,'^ '^"*^ electrical conductivity,^ '^^ '^"*^ ultrasound velocity,^'* against 
amphiphile concentration. 
As the cmc depends on the solution properties employed in the 
determination, its value differs with the method used. For this reason, measured 
cmc values define a narrow concentration range. 
Factors affecting the value of critical miceile concentration 
Since the properties of solutions of amphiphiles change markedly when 
micelle formation commences, a great deal of work has been done on 
elucidating the various factors that determine the concentration at which micelle 
formation becomes significant (i.e., cmc), especially in aqueous media. 
Among the factors known to effect the cmc markedly in aqueous 
solutions are: (i) structure of the amphiphiles, (ii) presence of various additives 
in the solution, (iii) experimental conditions such as temperature, pH, pressure, 
solvent, etc. 
(i) Structure of the amphiphiles 
In general, the cmc decreases as the hydrophobic character of amphiphile 
increases, i.e., cmc decreases as the number of carbon atoms in the hydrophobic 
group increases. In aqueous medium, ionic amphiphiles have much higher 
cmc's than nonionic amphiphiles containing equivalent groups. Zwitterionic 
amphiphiles appear to have about the same cmc's as ionics with the same 
number of carbon atoms in hydrophobic group. The cmc increases as the head 
group is closer to the center of the chain due to the two branches of the chain 
partially shielding one another, interfacial energy effects are smaller. In aqueous 
medium, the cmc's of ionic amphiphiles decrease as the hydrated radius of the 
counterion decreases. The presence of double bond in the chain also causes an 
increase in cmc. 
(ii) Presence of various additives in the solution 
(a) Effect of electrolytes 
In solutions of increasing ionic strength, the forces of electrostatic 
repulsion between head groups of an ionic micelle are considerably reduced. 
enabling micelles to form more easily, that is, at lower concentration. In other 
words, addition of electrolyte to ionic surfactants causes decrease in cmc,"*"* the 
effect being more pronounced for anionic and cationic than for zwitterionic 
surfactants, and more pronounced for zwitterionics than for nonionics. The 
effect of the concentration of electrolyte is given by the following equation'^'' 
log cmc = - a log C, + b (1.1) 
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where a and b are constants for a given ionic head at a particular temperature 
and Cj is the total (monovalent) counterion concentration in mole per dm . 
For nonionics and zwitterionics, Eq. (1.1) does not hold. Instead, the 
effect is given by the equation'*^: 
log cmc - -K Cs + constant (Cs < 1) (1-2) 
where K is a constant for a particular surfactant, electrolyte and temperature and 
Cs is the concentration of electrolyte in mole per dm . 
The change in cmc of nonionics and zwitterionics on the addition ot 
electrolyte has been attributed''^ ''^ ^ mainly to 'salting-out' or 'salting-in' (i.e., the 
effects of ionic size and decrease in dielectric constants) of the hydrophobic 
groups in the aqueous solvent by the electrolyte, rather than to the effect of the 
latter on the hydrophilic groups of the amphiphile. Electrolytes capable of 
'salting-out' reduce the cmc of nonionic surfactants while 'salting-in' 
electrolytes increase the cmc. The effect of the anion and cation in the 
electrolyte is additive and appear to depend on the radius of the hydrated ion, 
that is, the lyotropic number; the smaller the radius of the hydrated ion, the 
greater the effect. Thus the order of effectiveness in decreasing the cmc '^ is 
1/2 S04^- > F" > BrOs" > CI" > Br" > NOj' > T > CNS" and NH4^ > Na^ > Li^ > 
1/2 Ca . Tetraalkylammonium cations appear to increase the cmc, the order of 
effectiveness being'* :^ (C5H,,)4N^ > (C4H9)4N^ > (C3H7)4N^ > (C2H5)4N^ > 
(CH3)4N". 
(b) Effect of organic additives 
Quite small amounts of organic material can have a significant influence 
on the cmc, and the properties of micellar solutions. A knowledge of the effects 
of organic materials on the cmc of amphiphiles is therefore of great importance 
for both theoretical and practical purposes. 
It is common practice to divide organic materials into two main groups, 
depending on their mode of action in influencing the cmc. Group A is composed 
of molecules (like alcohols with moderate to long hydrocarbon chains) that 
appear to be adsorbed in the outer regions of the micelle, forming a palisade 
(i.e. fence-like) structure with the amphiphile molecules. This lowers the free 
energy of micellization to more negative values and so reduces the cmc; such 
molecules can also influence the micelle shape. Straight chain molecules have 
the most marked effect, the latter reaching a maximum when the length of the 
hydrophobic chain of the additive is about the same as that of the amphiphile. A 
decreased electrostatic repulsion between ionized head groups, and reduction in 
steric hindrance for nonionic amphiphiles have been proposed as likely 
explanations for these observed effects. 
Group B materials alter the cmc at substantially higher bulk 
concentrations and probably exert their influence through modification of the 
bulk water structure. The effect is usally discussed in terms of whether the 
additive is a (water) structure maker or a structure breaker. Typical 'structure 
makers' are xylose and fructose"*^ and 'structure breakers' are urea and 
formamide. '^^  
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Structure breakers increase the cmc of amphiphiles in aqueous solution. 
exerting their strongest influence on nonionic amphiphiles of the polyethylene 
oxide type. Presumably the presence of a structure breaker reduces the amount 
of water structure that the hydrophobic residues of the amphiphile can induce. 
The entropy increase on micelle formation is thus reduced and so the cmc is 
raised. The concept is not, however, a very straightforward one to apply. Even 
where the solute is able to interact very strongly with water its effect may be 
overall structure breaking, firstly because it has to pull water from its existing 
structure and secondly, because the resulting entity may substantially disrupt the 
remaining water structure.^' 
(in) Effect of experimental conditions 
(a) Temperature 
The effect of temperature on cmc of amphiphiles in aqueous medium is 
complex; the value appearing first to decrease with temperature to some 
minimum and then to increase with further increase in temperature. 
Temperature increase causes decreased hydration of the hydrophilic group, 
which favours micellization. However, temperature increase also causes 
disruption of the structured water surrounding the hydrophobic group, an effect 
that disfavours micellization. The relative magnitude of these two opposing 
effects, therefore, determines whether the cmc increases or decreases over a 
particular temperature range. From the data available, the minimum in the 
cmc—temperature curve appears to be around 25° C for ionics^^ and around 
50°C for nonionics.^ '^^ "* Data on the etYect of temperature on zwitterionics are 
limited. They appear to indicate a steady decrease in the cmc of alkylbetaines 
with increase in the temperature in the range 6-60° C.^ '^^ ^ 
Effect of temperature on nonionic surfactants is straightforward. The cmc 
of nonionic surfactants based on poly(ethyIene oxide) decreases with increasing 
temperature as the hydrophobicity of the PEO chain decreases." Several factors 
contribute to the decrease in hydrophobicity at a higher temperature but the 
three most important are: 
(i) change in water structure around the EO groups, 
(ii) change in hydrogen bonding to the EO groups, and 
(iii) change in preferred conformations of EO chain. 
(b)pH 
When amphiphile molecules contain ionizable groups such as —NH2, 
—(CH3)2N—>0 and —COOH, the degree of dissociation of the polar group will 
C O 
be dependent on pH. In general, the cmc will be high at pH values where the 
group is charged (low pH for -NH2 and -<CH3)2N^O, high pH for -COOH) 
and low when uncharged. Some zwitterionic surfactants become cationic at low 
pH, a change that can be accompanied by a rapid rise in the cmc,^^ or a more 
modest rise^° depending on the hydrophobicity of the zwitterionic form. 
(c) Pressure 
Many reports have appeared on the effect of pressure on micelle 
formation of the ionic '^"^^ and nonionic amphiphiles.^^ With pressure, cmc of 
ionic surfactants increases up to 1000 atm followed by a decrease above this 
pressure. ' Such behaviour has been rationalized in terms of solidification of 
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the micellar interior,^^ increased dielectric constant of water,^^ and other aspects 
related to water structure. For nonionic amphiphiles, the cmc value increases 
monotonously and then levels off with increasing pressure. La Mesa^' has also 
discussed the effect of pressure on the cmc. 
((I) Solvent medium 
For polyoxyethylenated nonionic solutions in benzene and carbon tetra -
chloride, cmc's decrease with increase in the length of the polyethylene group at 
constant hydrophobic chain length. 
The cmc of hexaoxyethylene dodecyl ether in cyclohexane saturated with 
water increases markedly with increase in temperature from 10-50 ° C.'^ ^ 
The cmc's in benzene for alkylammonium carboxylates increase with 
increase in the length of the alkyl chain of the anion but decrease with increase 
in the length of the alkyl chain of the cation; in carbon tetrachloride, there is no 
significant change in the value of the cmc with these structural changes. 
The cmc is lower in D2O than H2O for different amphiphiles. '^*'^ ^ The 
hydrophobic bonds are expected to be stronger in D2O than H20.^^ Micelles in 
D2O are larger than H2O 77 
Molecular shape 
The degree of interaction between water and amphiphilic molecules can 
be expressed by the molecular shape. The molecular shape is a term for how 
large the lipophilic region is compared to the hydrophilic region of the molecule 
and thus not depends on the actual atoms and covalent bondings within the 
molecule. Amphiphiles, which form spherical micelles in water, have a conkal 
^W *^'^ " 
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shape in this aggregate type. Cylindrically formed molecules have a polar 
region that is equal to the non-polar, whereas wedge-shaped molecules have a 
large non-polar region thus forming, for example, reversed micelles. Substances 
with one hydrocarbon chain often belong to the conical group whereas 
substances with two chains or one chain with unsaturations, giving kinks, 
belong to cylinders and wedges. 
The shape of the amphiphile aggregate is mainly determined by 
amphiphile packing parameter which is a dimensionless group relating the 
volume of the hydrocarbon tail of the amphiphile molecule (v), the length of the 
hydrophobic chain (Ic), and the head group area (ao)J^'^^ The packing parameter 
(Rp) is given by the expression 
Rp = v/a,4 (1.3) 
The optimum cross-sectional area per amphiphile molecule is observed 
experimentally by X-ray diffraction of bilayer systems while the volume and 
length of the hydrocarbon tail may be calculated by Tanford^ *^  equations: 
V = (27.4 + 26.9rt) A^ (1.4) 
4 = (1.5+1.265«)A (1.5) 
(n is the number of carbon atoms in the hydrocarbon chain) 
Considering the geometric dimensions, the volume and the surface area 
of each association structure yield critical conditions for the formation of each 
of the following shapes: 
spherical structures : Rp < 1/3 
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cylindrical structures 
bi layer structures 
inverted structures 
Types of micelles 
: 1/3 < Rp < 1/2 
: 1/2 < Rp < 1 
:Rp>l 
(i) Normal micelles 
The structure of a normal micelle just above the cmc can be considered 
o I 0-5 
as roughly spherical (Fig. 1.2). " When the hydrophobic portion of the 
amphiphile is a hydrocarbon chain, the micelle will consist of a liquid-like 
hydrocarbon core. The radius of this core is roughly equal to the length of fully 
extended hydrocarbon chain (~ 12-30 A). The polar head groups and bound 
water are regularly arranged at the micellar surface, which is rough.^ "^  Menger 
has proposed that water can penetrate inside the micelle upto a certain level,^ '^ '**^  
the idea gets support from fluorescence and 'H—NMR measurements. Partial 
molar volume determinations indicate that the alkyl chains in the core are more 
expanded than those in the normal liquid state.^^ 
The nonionic micelles arrest water molecules at the palisade layer (which 
includes the head groups and the first few methylene groups) by hydrogen 
bonding of water with the polyethylene oxide groups.^^ Water may remain 
trapped in this region. 
In ionic micelles, the surface potentials are high **'*'^^ and a significant 
fraction of the counterions (60-90%)^° are located in a compact region, known 
as 'Stern layer',^'* which extends from the core to within a few angstroms of the 
shear surface of the micelle. The core and the Stern layer form the 'kinetic 
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Fig. 1.2: A two-dimensional schematic represeniation of regions of a spherical 
ionic micelle. The counterions (X), the head groups (O), and the hydrocarbon 
chains (N\N) are schematically indicated to denote their relative locations but 
not their number, distribution, or configuration. 
micelle'. Most of the remaining counterions are, however, located outside the 
shear surface in the region called 'Gouy-Chapman electrical double-layer'. 
According to Hartley model, the overall volume of a micelle is approximately 
twice that of Stern layer.^''^^ 
Counterions are "bound" primarily by the strong electrical field created 
by the head groups but also by specific interactions that depend upon head 
group and counterion type. '^  ' ^ A two-site model has been successfully 
applied to the distributions of counterions; i.e., they are assumed to be either 
"bound" to the micellar pseudophase or "free" in the aqueous phase.^ ''"^^ The 
head group and counterion concentrations in the interfacial region of an ionic 
micelle are on the order of 3-5 M, which gives the micellar surface some of the 
properties of concentrated salt solutions.^ '^^ '^^ ^ Although the solution as a whole 
is electrically neutral, both the micellar and aqueous pseudophases carry a net 
charge because thermal forces distribute a fraction of the counterions radially 
into the aqueous phase. ' 
(ii) Reverse micelles 
Amphiphiles in non-polar solvents in presence of traces of water 
associate to form the so-called reverse, inverted or reverted micelles. The 
structure of micelle is similar to that of normal micelle but inverted, i.e., the 
polar head groups of the monomers being present in the center and the 
hydrocarbon chains extending outwards into the solvent. ^ '^^ ^ Water forms a pool 
in the interior of the micellar aggregate. The size and properties of reverse 
micelles vary with the amount of water present.'°°'"^' 
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Water in reverse micelles is expected to behave very differently from 
ordinary water because of extensive binding and orientation effects induced by 
polar heads forming the water core. 
(Hi) Mixed micelles 
When two or more type of amphiphiles are in solution, a complex 
balance of intermolecular forces is responsible for the formation of mixed 
micelles against the formation of micelles constituted by amphiphiles of one 
type. Further, mixed micelles provide better performance characteristics in their 
applications than those consisting of only one type of amphiphiles. "^ '^ "'^ ^ Clint' 
developed analytical description which contained both micelle composition and 
monomer concentration above the mixed cmc for mixtures of nonionic 
surfactants. Clint's treatment assumed ideal mixing in the micelle. The 
properties of the mixtures of ionic and nonionic amphiphiles"^^"'" have been 
interpreted with the aid of mixed micelle formation. It was pointed out that the 
cmc of the mixed surfactants was lower than either of the single 
surfactants. "^ -^"^  
Mixed micelles may also form when low molecular weight solutes are 
solubilized by micelles of amphiphiles containing a relatively larger non-polar 
side chain. The solubilized substances, also called as the penetrating additives,^^ 
may be located in both the hydrocarbon core"'' and in the hydrophilic 
mantle. "^-"^ 
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The occurrence of mixed surfactants and hence mixed micelles are 
common in industrial, pharmaceutical and biological fields; physicochemically, 
they work better than pure amphiphiles in solution. 
(B) Drugs and Their Classification 
The term drug is derived from the French word 'Drogue' which means 'a 
dry herb'. According to definition of the World Health Organization, a drug is 
any substance or product that is used to modify or explore physiological 
systems or pathological states for the benefit of the recipient."^ In the context of 
medicine, it means a chemical used in the prevention, diagnosis or treatment of 
diseases. 
It is to be noted that drugs are to be used for the benefit of recipient and 
h is presumed that this refers to total benefit—physical, mental as well as 
economical. 
Drugs are regarded as biologically active chemical compounds mostly 
with a therapeutic purpose which can be broadly classified into: 
I. Biological classification 
II. Chemical classification 
III. Classification of drugs according to commercial consideration 
IV. Classification by the lay public. 
I. Biological classification 
Biological classification is based on pharmacotherapeutic and 
chemotherapeutic agents, i.e., this is as disease oriented classification of 
medicinal agents used in various diseases and hence this classification is based 
on medicinal agents which are overall descriptive but not very accurate on 
scientific grounds. The broad classification based on gross overall biological 
effects is as follows: 
(i) Drugs acting on central nervous system and peripheral nervous system 
These drugs act on the central nervous system (CNS) of the human body 
which consists brain and spinal cord, and controls and regularizes the special 
functions like circulation, digestion and respiration and it also modifies the 
psychic reactions such as feeling, attitude, thoughts, memory. 
The drugs, which affect the central nervous system, can either stimulate 
or depress the central nervous system. 
(ii) Chemotherapeutic drugs 
Chemotherapy can be defined as the "use of chemical compounds in the 
treatment of infectious diseases." Various drugs used in chemotherapy are 
known as chemotherapeutic drugs, which have important therapeutic use in the 
treatment of parasitic infections due to insects, worms, protozoa, viruses, 
bacteria, etc. These drugs destroy offending parasites or organisms without 
damaging the host tissues. 
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A chemotherapeutic agent may act by destroying the organism, i.e., it is 
bactericidal or by inhibiting the growth, i.e., it is bacteriostatic. The efficiency 
of the chemotherapeutic agent depends upon the normal body defense 
mechanisms and the development of resistance by the micro-organisms to the 
particular agent. Host plays an important part in the curative action of most of 
the specific remedies. 
(Hi) Pharmacodynamic agents 
These drugs affect the normal processes of the body like blood 
circulation, hemodynamic process, i.e., blood pressure, cardiac outputs, etc. 
Pharmacodynamic agents include mainly the drugs which affect the heart and 
blood circulation. It also includes a wide variety of drugs used in allergic and 
gastro intestinal diseases. 
(iv) Metabolic diseases and endocrine function 
It includes variety of drugs which are not conveniently classified in the 
other groups. It includes the following groups of drugs: 
(a) antirheumatic and autoimmuno disease drugs 
(b) dermatologicals (used in skin diseases) 
(c) drugs used in endocrine disorders 
(d) anti-inflammatory drugs. 
II. Chemical classification of drugs 
Chemical classification is based on their chemical structure. According 
to this classification drugs may come under one or more of these categories 
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such as quinines, semicarbazides, phenols, lactones, azo compounds, amides. 
alcohols, acetals, ketones, hydrocarbons, halogenated compounds, guanides, 
enols, esters, etc. 
The implication of this classification is that similar chemical structure 
should yield similar biological activities. Thus, structurally close analogous 
compounds are grouped together with some overall activity but sometimes this 
classification is not very accurate as a few compounds with similar structure 
lack the activity test. Chemical structural classification of drugs is of advantage 
for study of methodology and structure-activity relationship. 
III. Classification of drugs according to commercial consideration 
The manufacturers and distributors of therapeutic agents classify the 
drugs according to their operational expenses, research investment and profit 
margins. Medicines for relatively rare diseases are called orphan drugs and 
such drugs lack patient protection as production costs are high and demand is 
less. 
Another classification of commercial consideration depends on the way 
of administration of drug, i.e., drugs are given orally, parenterally (meaning-
introduced subcutaneously, intraveneously or by any route other than by way of 
the digestive tract) by inhalation, sublingually, rectally, etc. On the whole, 
orally active drugs are preferred by physicians and patients. 
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IV. Classification by the lav public 
The few broad public classification depends on the action of the drug, 
for example, antiseptic and disinfectant, anthelmintics, expectorants, cough 
mixtures, laxative and purgative, analgesics, tonics, ointments for skin diseases, 
etc. but this classification is scientifically inadequate and public should be well 
informed about all aspects of the chemistry, biological action and fate of 
medicinal agent by experimental biologists and medicinal chemists. 
Many pharmacologically active compounds are amphiphilic or 
hydrophobic molecules, which may undergo different kinds of association, and 
whose site of action in the organism frequently is the plasma membrane. Even 
if their target is intracellular, the interaction with this first barrier plays a 
1 1 R 
fundamental role. 
Classes of amphiphilic drugs include phenothiazine"^"'^^ and 
benzodiazepine'•^° tranquillizers,'^'"'^'' analgesics,'^^ peptide'^^ and non 
peptide'^^"'^^ antibiotics,'^^"''" tricyclic antidepressants,'''^"''''' antihistamines, 145 
anticholinergics,'''^ y9-blockers,'''^ local anesthetics (LA),'''^"'^^ non-steroidal 
antiinflammatory drugs,'^''anticancer drugs.'^'' Many of these drugs contain one 
or more (condensed or not) aromatic nuclei, while others are of peptide nature. 
A great deal of data on the surface active properties of drugs can be found in the 
book by Attwood and Florence,'^ and other reviews.'^^"'^^ 
Surface active drugs of quite different chemical structure are reported to 
self-associate and bind to membranes, causing disruption and solubilization, in a 
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surfactant-like manner. Depending on the kind of drug, the self-association of 
these drugs is classified into two modes: micellar and nonmicellar aggregations. 
Here the micellar aggregation means that a single multimer (micelle) forms 
above the cmc, and nonmicellar (stepwise) aggregation means that i-mer is 
successively formed by aggregation of (i - l)-mer and monomer.'^^ 
(C) Clouding Phenomenon in Aqueous Solutions 
When two neat liquids are brought together, they may either mix into a 
homogeneous solution or they may form two solutions, where in each case one 
of the components can be regarded as the solvent. Normally in the latter case, 
the compositions of the two phases in equilibrium become more equal when the 
temperature is increased. The explanation is simple and can be expressed in 
terms of minimization of the free energy. From standard thermodynamics we 
know that 
AG = AH-TAS (1.6) 
where H is the enthalpy and S the entropy. In terms of simple models such as 
the regular solution theory,'^ '' ^ this is a consequence of the relative 
temperature independence of AH and AS. This means that the main temperature 
dependence comes from TAS. This quantity is a measure of the disorder in the 
system, and when a mixture is formed the disorder is normally increased. 
Consequently, we may expect the entropy of mixing to be a positive quantity 
that favours mixing, and that this effect becomes more important at higher 
temperatures. 
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There are, however, frequent exceptions from this expected behaviour. 
Such systems are represented by liquids that are completely miscible at low 
temperatures but phase separate when heated. This is observed by the clear 
solution present at low temperatures suddenly becoming cloudy on heating. The 
temperature where this occurs is referred to as the cloud point (CP). 
Binar>' liquid mixtures that display partial miscibility exhibit critical 
solution temperatures (CST) or consolute temperatures. CST's are of two kinds: 
upper critical solution temperature (UCST), above which the liquid pair is 
completely miscible and below which phase separation occurs, and lower 
critical solution temperatute (LCST) below which two components are 
completely miscible while above it the two components become partially 
miscible and form two separate phases. The appearance of LCST is a rather rare 
phenomenon for solutions of small molecules but is more frequent when at least 
one of the molecules is large. The importance of the entropy of mixing, which 
favours mixing, becomes relatively less important when the molecules get 
larger and the mixing process becomes more dominated by the enthalpy term, 
which may favour or disfavour mixing. 
If the solution is cold, a temperature below which the amphiphile is not 
really very soluble (Fig. 1.3) at all is reached, known as the Krafft 
temperature. " If, on the other hand, the temperature is raised, especially for 
nonionic amphiphiles or those with some nonionic polar groups, a two-phase 
region is encountered, above what is known as the CP'^ *"'^ ^ where two liquid 
(micellar) phases are in equilibrium. Finally, if we increase concentrations at 
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Fig. 1.3: Schematic temperature (T)-concentration phase diagram illustrating the 
types ofamphiphile aggregates encountered by moving away from the micellar 
region. 
28 
ambient temperature, one starts to encounter, usually at amphiphile 
concentrations above 40 % by weight, a series of mesomorphic phases 
sometimes called liquid crystalline phases. 
It is well known that CP is a common property of many aqueous 
nonionic surfactant solutions. ''^ Below CP, a single phase of molecular or 
micellar solution exists, above it water solubility of surfactant is reduced and a 
cloudy dispersion results. The phenomenon is reversible and the CP stands 
for transition from water soluble state to oil soluble state.' ' CP is very sensitive 
to the presence of additives in a system, even at a very low concentration. The 
additives modify the surfactant-solvent interactions, change the cmc, size of 
micelles and phase behaviour in the surfactant solutions.'^^ Many efforts have 
been made to investigate the effect of various additives, e.g., electrolytes, 
organic compounds, ionic surfactants, cationic surfactants and zwitterionic 
surfactants on the cloud point of nonionic surfactants."^' '^^'^°^ 
Generally, the clouding behaviour would not happen in ionic surfactant 
systems because of significant electrostatic repulsions between the charged 
aggregates. Nevertheless, previous researches showed that aqueous solutions of 
some ionic surfactants with high salt concentration, ' salt free aqueous 
solutions of certain ionic surfactants with large head groups,^ "'^'^ or large 
counterions,^' "^ '^  and some mixed cationic and anionic surfactant 
solutions also exhibited the above behaviour. The mechanism of the 
behaviour in these ionic surfactant solutions is still an open 
^ ^.<--^ 207,215,217,218 
question. 
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Mechanisms for phase separation 
The surfactant/salt solutions phase separate upon either heating or 
cooling depending on the salt type and composition. Phase separation on 
•y 1 Q 
cooling is akin to a gas-liquid transition and occurs when attractive 
interactions between the constituent entities become sizable with respect to the 
thermal energy. Adding salt screens the electrostatic repulsions between the 
surfactant micelles. An attractive potential well due to van der Waals forces 
can then arise between the micelles, eventually causing phase separation at low 
temperatures."^^^ Adding more salt weakens repulsions, and the system therefore 
phase separates at higher temperatures. 
Phase separation on heating is a more complex phenomenon and has 
been explored in detail previously in the context of nonionic surfactant phase 
behaviour. In the few cases where this phenomenon has been observed for 
ionic surfactant solutions, the surfactant head group was large and 
hydrophobic ' or the salt concentrations were extremely high. The results 
show that neither of these factors is the key requirement. What, then, controls 
the phase separation on heating? Two different arguments are presented below. 
(a) Attractive interactions between pseudo-nonionic micelles 
The phase separation on heating would then be a natural outcome of the 
nonionic micellar character. This stems from the observation that clouding 
occurs only in the presence of hydrophobic counterions such as salicylate and 
tosylate that remain strongly bound to micelles.^ '^"^ '^* These counterions are 
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supposed to be oriented perpendicular to the micellar surface plane, with the 
hydrophobic portion penetrating into the non-polar interior of the micelles and 
the negative charge located at the surface adjacent to the positively charged 
surfactant head groups.'^ ^^ The head groups and the counterions can thus form 
complexes at the micellar surface, and the neutralization of surface charge 
imparts nonionic character to the micelles. Interestingly, such pseudo-nonionic 
complexes have been found in some mixtures of cationic and anionic 
surfactants '^^ '^ '^ '^ ^ '^'^ ^^ and indeed these mixtures show cloud points. 
The nonionic character of the micelles will then be a function of 
composition and will depend especially on the fraction of salt that remains 
bound to the micelles. 
The discussion thus far assumes that pseudo-nonionic micelles will 
develop attractive interactions on heating. The molecular origin of such 
attractions is a matter of speculation, and it is not evident that hydrogen-
bonding interactions play a role. Warr et al. ' advanced a mechanism 
involving hydration shells to account for cloud points, whereas Appell and 
Porte^°^ interpreted the clouding of CPyBr/NaClOa mixtures as being 
analogous to the phase separation of polymers in a poor solvent. Thus, the 
overall manifestation of the interactions is that water functions as a good 
solvent for the micelles at low temperatures and becomes a poor solvent at high 
temperatures. 
(b) Microstructiiral changes from linear to branched micelles 
An interpretation of the observed cloud points in terms of attractive 
interactions ignores the dramatic microstructural changes occurring as a 
function of composition and temperature that are indicated by rheological 
measurements. The viscosity of surfactant as a function of salt (NaTos or 
NaSal) shows two maxima, one at low and the other at high salt concentrations. 
Because of the intervening two-phase region, there is a break in the curve that 
obscures the viscosity minimum. Other mixtures of a cationic surfactant and a 
binding salt, show a continuous curve with similar viscosity maxima flanking a 
viscosity minimum. Thus the data are analogous, barring the phase separation 
at intermediate salt in the present case. 
Yu and Xu^''' proposed a mechanism for clouding in tetrabutyl 
tetradecyl sulfate. They postulated that butyl chains belonging to TBA^ 
associated with one micelle could cross-link to another micelle helping 
overcome the effects of electrostatic repulsion and an energetic barrier due to 
oriented water near the surfaces of the two micelles. To be operative 
geometrically, it appears that the two micelles would have to approach one 
another intimately due to the limited extent of the short butyl chains. 
Bales and Zana ' " opposed the mechanism for clouding in TBADS 
(or SDS + TBA) which explains that reducing the water hydrating the micelle 
is responsible for CP, but the details are not clear. That hypothesis is supported 
by the fact that alkylammonium counterions are quite bulky and ought to expel 
water from the palisade layer in the same way that bulky head groups do.^^' 
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Measurements of the water content of the paHsade layer will be needed to 
confirm this expectation. If mdeed clouding is induced somehow by 
dehydrating the micelle surface, then the intepretation of the data will be 
further complicated by presence of Na^ because increasing the aggregation 
number of a globular micelle leads to less water per surfactant. ' This is a 
consequence of the fact that the surface area of a micelle grows more slowly 
than its volume, leading to a smaller volume per surfactant in which to fit the 
water.^ ^ '^'^ ^^ Adding Na"^  increases the aggregation number of SDS. Therefore, 
there would be two competing mechanisms to dehydrate: one by displacement 
of water by the counterions and another by the geometric constrictions due to 
micelle growth. Therefore, one would need to know the details of the micelle 
aggregation numbers in the presence of both TBA"^  and Na"*^  to gain a clear 
understanding. 
To the previously suggested mechanisms for clouding in ionic micelles, 
they suggested^^^ that a second layer of TBA"^  is loosely attached outside the 
polar shell of the TBADS micelle because steric restrictions did not appear to 
allow enough available volume to house a sufficient number of counterions to 
yield the values of R. If this second layer is in fact available, the crosslinking 
between micelles could take place between butyl groups of the TBA"^  ions in 
the second layer. This possibility is supported by the tendency of TBA"^  ions to 
self-associate. 
So far, most of these studies on clouding behaviour in ionic micellar 
solutions were made in systems where tetrabutylammonium ion (TBA"^ ) was 
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added either externally or was part of the surfactant monomer.^ '^ "^^ '^ '^ ^ '^"^ "^ -^ ^ 
Also, the variation of head group from tripropyl- to tributylammonium in a 
cationic surfactant caused the observance of clouding in solutions on 
heating.^ "'^'^ These results suggest the crucial roles played by temperature and 
alkyl chains present near the head group region in dictating the macroscopic 
properties of the surfactant solutions. The above studies justify a need to know 
details of micellar morphologies that lead to clouding. 
Recent inyestigations '^'^ " '^*^ show, however, that clouding also occurs in 
formamide, another polar solvent and, in the original work of Saeki et al.,^ "*' 
clouding of PEO was observed also in /-butylacetate, a non-hydrogen-bonding 
(with itself and EO) liquid. 
Recently, Kim and Shah^ '*^ "^ '*'' have observed the CP phenomenon in 
amphiphilic drug amitriptyline hydrochloride solutions and have explored the 
effect of additves. 
(D) Relevance of the Problem 
It was shown by Mouritsen and Jorgensen '^*^ and Tieleman et al.^ "*^  that 
amphiphilic drugs insert into membranes as interstial components and they 
affect the organization of lipids. Although the pharmacological effects of 
amphiphilic drug molecules are usually manifest at low concentrations where 
self-association is negligible, it is likely that accumulation of drug molecules at 
certain sites in the body may cause a localized high concentration resulting in 
aggregation and consequent changes in biological activity due to decreased 
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transport rates or decreased ability to pass through biological barriers'^^ and 
may prove harmful. 
These drugs, because of their surfactant-like nature, exhibit 
concentration, temperature and pH-dependent phase separation.^ ''^ ''^ '*'* It was 
observed that CP can vary with additives. 
When using these drugs it should be kept in mind that normal human 
body temperature is typically 12 degrees above ambient. Even if the CP of pure 
drug in buffer is above this temperature, it may decrease in presence of 
additives, especially surfactants which are used as drug carriers. As clouding 
concentrates the drug in a small volume, it may affect the activity of drugs and, 
therefore, it is important to have a knowledge of clouding behaviour of these 
drugs in designing more effective drug-carrier combinations. With this idea in 
mind, effect of various additives, viz., electrolytes, non-electrolytes, alcohols, 
amino acids, sugars, polymers, surfactants and their concentration effects have 
been examined on CP behaviour of drugs. 
(E) Layout of the Thesis 
This thesis consists of four chapters including this one which is 
concerned mainly with the general introduction of amphiphiles; the factors 
responsible for the formation of various aggregation patterns, their solution 
properties, e.g., cloud point phenomenon, etc. From the literature survey it 
appears that exploring CP in amphiphilic drugs in presence of additives is a 
recent phenomenon. 
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Chapter-II includes the methodologies which were used in the studies. 
Materials used, individual purity, make, etc. are also included in tabular form. 
Chapter-Ill contains cmc data for two antidepressant (AMT and IMP) 
and two phenothiazine (CPZ and PMT) drugs in aqueous media. Effects of 
some selected additives on the cmc of these drugs in aqueous solution are also 
reported. 
Studies on the effect of various additives on the CP values of two 
antidepressant and two phenothiazine drugs are described in Chapter IV. 
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The materials used throughout the study are given in Table 2.1, including 
their abbreviated names, chemical formulas/structures, sources, and purities. 
All the drugs as well as additives (electrolytes, ureas, sugars, surfactants, 
amino acids, alcohols, polymers) were used as received. 
Gemini surfactants were synthesized in the laboratory by the following 
method:' 
Dry EtOH + + 
Ci6H33NMe2+(CH2)„,Br ^ C,6H33Me2N(CH2);„NMe2C,6H33 
Reflux, >80°C, 48 h 
( - = 4,5,6) Br Br 
A 2.1:1 equivalent mixture of A^ , iV-dimethylhexadecylamine with 
corresponding a, co- dibromoalkane (w = 4, 5, 6) in dry ethanol was re fluxed (at ~ 
80 °C) for 48 h. The progress of the reaction was monitored using TLC technique. 
The solvent was removed under vacuum from the reaction mixture and the solids 
thus obtained were recrystallized several times from hexane/ethyl acetate mixture 
to obtain the compounds in pure form. The overall yields of the surfactants ranged 
from 70 to 90%. Purity of all the gemini surfactants was checked on the basis of C, 
H, N analyses and surface tension measurements and further characterized by ' H 
NMR.''2 
Hygroscopic chemicals (drugs: CPZ, PMT, IMP, all quaternary salts, LiCl, 
LiBr, etc.) were stored in desiccators. AMT was kept in a refrigerator (at 2-4° C). 
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CPZ, PMT and IMP are not only hygroscopic but also photosensitive. So they 
were stored in desiccators at a dark place (wrapped in aluminum foil). 
All solutions were prepared in doubly-distilled deionized water. The 
specific conductivity of the water was in the range 1-2 x 10"^  S cm"'. 
Special care was taken for cleaning the glasswares, which were properly 
washed with freshly prepared chromic acid and distilled water thencruis,ed with 
acetone and kept in oven for drying before use. r 
Preparation of Sodium Phosphate Buffer Solutions: \ \ 
10 mM sodium phosphate (SP) buffer solution was prepare4_:;ft£iaF=^ 
monobasic monohydrate (X mM) and SP tribasic dodecahydrate (Y mM) and 
subsequently used throughout as solvent for CP measurements. ' (For AMT: X = 
6.1, Y = 3.9; for IMP: X = 6.0, Y = 4.0; for CPZ: X = 6.0, Y = 4.0; for PMT: X = 
5.5, Y = 4.5). 
For the pH variation, the 10 mM SP buffer ratios of X and Y were: X = 9.5, 
Y = 0.5; X = 9.0, Y = 1.0; X = 8.0, Y = 2.0; X = 7.0, Y = 3.0; X = 6.0, Y = 4.0; X 
= 5.0,Y = 5.0;X = 4.0, Y = 6.0. 
cmc Determination: 
(a) by surface tension measurements 
Surface tension is probably the most common means of determining the 
cmc of amphiphilic compounds. The method is fast, convenient, and non-
destructive to the amphiphilic drugs. Below cmc, amphiphilic molecules position 
;/ 
56 
themselves at the air/water interface and thus lower the surface tension. Above the 
cmc, any added amphiphile monomer prefers to join micelle rather than to enter 
the interfacial film. 
The cmc of drugs (with and without additives) in pure water were 
determined by measuring the surface tension (ST) of pure drugs as well as drugs + 
additives (NaCl, CTAB, TX-lOO) solutions of various concentrations at room 
temperature. 
The cmc values were obtained by plotting ST vs log [drug]. The constancy 
in ST vs log [drug] plots was taken as the cmc of the drugs. 
The surface tensions were measured by the ring detachment method using a 
S. D. Hardson tensiometer (Kolkata, India). 
(b) by dye solubilization method 
The term solubilization implies the formation of thermodynamically stable 
isotropic solution of a subtrate (the solubilizate), normally insoluble or only 
slightly soluble in a given solvent, by the addition of an amphiphile (the 
solubilizer).^ Solubilization is of course, closely related to micellization since little 
or no solubility increase is observed until the cmc of the amphiphile is reached, 
but once the micelles are folly formed its increase is directly propotional to the 
concentration of the amphiphile over a large range. 
Dye solubilization experiments for the aqueous drug solutions (with and 
without additives) were performed at room temperature. The sample solutions 
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with Sudan III dye were kept for 24 hours, filtered and then UV-visible 
absorbance was recorded in the wavelength range of 400-600 nm using a UV-
visible spectrophotometer (Cintra 5, GBC Scientific Equipment, Australia). 
Cloud Point Measurements 
Cloud points (CP) were obtained by placing Pyrex glass tubes (containing 
the sample solutions) into a temperature-controlled bath (designed and assembled 
in the laboratory with commercially available components). The temperature was 
ramped at the rate of 0.1° C/min near the CP. Because of the suddenness and 
sharpness of the phase separation, visual inspection was sufficiently accurate for 
CP measurements, so, clouding was noted by visual inspection. However, the 
temperature was oscillated slowly through the CP until it was reproducible.''""^ 
Similar CP measurements were made by using different [additive] at fixed [drug] 
(50 mM except with [IMP] = 100/150 mM — because of solubility variation 
depending on the nature of additive, higher IMP concentration was used; the Kraft 
temperature of IMP in 6.7 SP buffer ~ 42 °C). This was done by diluting the 
sample to smaller concentrations and repeating the same procedure. These 
experiments were perfomied to obtain the minimum [drug] required to observe the 
clouding phenomenon. 
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Self-association of amphiphilic compounds is a possible way of 
eliminating the energetically unfavourable contact between the non-polar part 
and water while simultaneously retaining the polar part in an aqueous 
environment. The physical phenomenon responsible for such behaviour is 
referred to as the hydrophobic effect and arises from a subtle balance between 
1 2 
intermolecular energies and entropies. ' 
A large number of drug molecules are amphiphilic and self-associate in 
aqueous environment to form small aggregates. Their "surfactant-like" 
behaviour is due to the presence of an almost planar tricyclic ring system and a 
short hydrocarbon chain carrying a terminal nitrogen atom.'^ '"' Depending upon 
the solution pH, the drug monomers may acquire cationic (i.e., protonated) or 
neutral (i.e., deprotonated) form. 
Drug self-association depends on the molecular structure of the drug, 
concentration, and physicochemical conditions such as temperature, pH, ionic 
strength and additive concentration. It has been established from earlier studies 
on drugs that aggregates of approximately 6-12 monomers are formed in water 
above cmc. 
It is well known that cmc of amphiphiles varies in presence of additives, 
because the interfacial and micellar properties of these compounds in solutions 
are governed by a delicate balance of hydrophobic and hydrophilic interactions. 
These characteristics can be modified in two ways: (i) through specific 
interactions with the amphiphile and (ii) by changing the nature of solvent.^ As 
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drugs are used in combination with additives (e.g., surfactants), it is necessary 
to have a knowledge of additive effect on the cmc of amphiphilic drugs. 
With this viewpoint the surface tension (ST) and dye solubiHzation 
studies have been performed on aqueous solutions of four amphiphilic drugs, 
amitriptyline, AMT; imipramine, IMP (antidepressants); chlorpromazine, CPZ; 
promethazine, PMT (phenothiazines) to determine the cmc of these drugs in 
presence of different additives, viz. NaCl, CTAB, TX-100. Surface properties, 
namely maximum surface excess concentration (/"max) and minimum area per 
molecule (^ min) are also calculated. 
Results 
Representative plots of ST vs log [drug] for the four drugs with different 
additives are shown in Figs. 3.1-3.6. The cmc, f^ax, and A,„,„ values with and 
without additives are presented in Table 3.1 and shown graphically in Fig. 3.7-
3.9. Based on the spectra of Sudan III in 50 mM drug (AMT, IMP, CPZ and 
PMT) solutions with and without fixed concentrations of additives (400 mM 
NaCl, 1.0 mM CTAB and 0.3 mM TX-100 — Figs. 3.10 and 3.11), the cmc 
values of the drugs were determined using the dye solubilization method also 
(Figs. 3.12-3.17). Table 3.2 records the results (see Fig. 3.18-3.20 also). The 
values for pure drugs have been found to be in good agreement with the 
literature values.^ 
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Discussion 
The cmc values of all the drugs have been found to decrease in the 
presence of additives (NaCl, CTAB and TX-lOO — Tables 3.1 and 3.2). 
Counterions are bound to micelles primarily not only by the strong electrical 
field created by the head groups, but also by specific interactions that depend 
upon the head group and the counterion type. Two mechanisms have been 
proposed: In one mechanism, inorganic salts affect the solvent property of 
water while in another, ions affect the micelles directly by adsorbing/desorbing 
to the head group region of the micelles. ' Counterion binding plays a role to 
decide the effective charge on the micelles and hence its formation, shape, and 
mutual interactions.'' Added CF ions (in the form of NaCl) follow the second 
mechanism and adsorb to the cationic head group region of the drug 
monomers. This adsorption decreases the electrostatic repulsion among head 
groups and less electrical work is required to form micelles. With CTAB and 
TX-lOO also cmc's show a decrease. The concentrations of these surfactants 
were lower than or equal to their cmc values (which are 1 mM — CTAB and 
0.36 mM — TX-lOO'^). Further, these surfactants are known to form mixed 
micelles with the drugs. 
The physicochemical properties of mixed micelles are quite different 
from those of pure micelles of the individual components. The micellar 
aggregation number and the association of counterions with micelles change 
dramatically with composition in mixed micelles. The degree of counterion 
association of an ionic micelle is about 0.7 for monovalent counterions. 
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However, when an ionic surfactant is mixed with a non-ionic surfactant, the 
degree of the association falls to zero as mole fraction of nonionic surfactant in 
the micelle increases.''*''^ Most cmc's of binary mixtures fall between the cmc 
of the two components but some fall above'^ or below'^ this range. Our results 
for cmc's of the drugs in presence of TX-lOO or CTAB show the same 
behaviour. Addition of TX-lOO assists in micelle formation of drugs. TX-lOO 
(by penetrating into the micelles) lowers the repulsive forces between the polar 
head groups of the drugs. 
Rodriguez et al.''' studied the effect of dodecyltrimethylammonium 
bromide concentration on the cmc of AMT in aqueous solution by conductivity 
and static fluorescence measurements. They explained their results on the basis 
of mixed micelle formation. Theoretical calculations of their results predict an 
apparent ideal but non-synergistic behaviour of the mixed micelles. Our results 
also indicate mixed micelle formation, although the slope of cmc decrease is 
lower in case of CTAB. 
It is well known that the air-solution interface of an amphiphile solution 
is well populated'^ by the adsorbed molecules. Accordingly, it has been shown 
that the concentration of the surfactant is always more at the surface due to 
adsorption over and above the concentration of surfactant in the bulk. 
The surface excess concentration, /"max^  is an effective measure of the 
Gibbs adsorption at liquid/air interface, /"max was calculated by applying Gibbs 
equation'^ 
i'^'^'^ r 
rn,ax = - ( d y / d l 0 g c ) T \ \ > .^  ^ ^ / (3 .1 ) 
2.303 nRT V "^ ^ ^ j ^ 
where y, R, T and c are surface tension, gas constant, absolute temperature and 
concentration, respectively. The variable n is introduced to allow for the 
simultaneous adsorption of cations and anions. The expression used in the 
calculation of n was that proposed by Matijevic and Pethica,^ *^ n = 1+ 
m/(m+ms), where mj is the concentration of the added electrolyte. Thus, n has a 
value of 2 in water and approaches 1 in the presence of excess inert electrolyte. 
The slope of the tangent at the given concentration of the y V5 log c plot was 
used to calculate /"max-
7"max increases with the increase in concentration of additives (Table 3.1). 
The drug solutions with additives, compared to pure drug solutions, have 
greater preference to be adsorbed at the air/water interface. The presence of 
additives decreases the repulsion among head groups and more drug molecules 
can adsorb at the interface which is also confirmed by low values of ^ mm (Table 
3.1). 
^min was evaluated using the relation 
^, ,„=10'VNAr„, ,xA' (3.2) 
where NA is Avogadro number. The data show the expected area decrease with 
increasing additive concentration. This is due to progressive charge shielding 
and closer packing of the drug ions in the surface. The low values of n^im 
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suggest that the orientation of the surfactant molecule at the interface is almost 
perpendicular to the interface.'^ The values of n^im for these drugs are similar to 
those reported for other antidepressants and phenothiazines. 
An important property of micelle that has a particular significance in 
pharmacy is their ability to increase the solubility of sparingly soluble 
substances.^ ''^ '*"^^ A number of approaches have been taken to measure 
solubilizing behaviour of amphiphiles in which the solubilization of water 
insoluble dye in the surfactant micelles was studied.^^ Fig. 3.10 and 3.11 plots 
show that in the presence of additives micelle size increases and more dye can 
solubilize in the aggregates. The plots of absorbance vs. [drug] used to evaluate 
cmc values in the absence as well as presence of different fixed concentrations 
of additives — Figs. 3.12-3.17 — reveal that the amount of the dye solubilized 
was little upto the drug cmc and, with the formation of micelles, a sudden and 
steep rise was observed. Effect of additive concentration on cmc values of 
drugs determined as above are collected in Table 3.2 (see Figs. 3.18-3.20). 
Differences between the cmc values obtained by surface tension and dye 
solubilization techniques (Tables 3.1 and 3.2) arise because the techniques 
measure different underlying phenomena. 
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Table-3.2: Effect of additive concentrations on the cmc values of amphiphilic 
drugs in aqueous solutions at ~ 27 °C determined by dye 
solubilization method. 
[Additive]/mM 
NaCl 
0 
100 
200 
300 
400 
CTAB 
0.25 
0.50 
0.75 
1.00 
TX-lOO 
0.075 
0.150 
0.225 
0.300 
AMT 
38.75 
33.98 
32.71 
28.29 
23.25 
24.20 
11.75 
5.40 
1.64 
23.53 
12.50 
6.60 
2.17 
IMP 
48.33 
43.43 
38.57 
35.81 
33.12 
38.00 
27.64 
14.74 
3.78 
38.44 
25.63 
13.99 
3.22 
CPZ 
18.22 
14.46 
12.46 
11.20 
7.95 
12.23 
9.27 
4.02 
1.63 
12.17 
9.02 
4.31 
1.39 
PMT 
47.40 
39.74 
38.27 
34.10 
30.17 
37.54 
25.61 
12.15 
3.28 
36.77 
25.14 
12.62 
2.83 
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Fig. 3.1: Plots of surface tension vs logarithm of AMT (A) and IMP (B) 
concentration at different fixed concentrations ofNaCl. 
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Fig. 3.2: Plots of surface tension vs logarithm of CPZ (A) and PMT (B) 
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Chapter-IV 
Effect of Additives on the 
Clouding Behaviour of 
Amphiphilic Drug Solutions 
105 
Non-ionic surfactants generally'"-^ and ionic surfactants in special 
conditions " undergo clouding phenomenon. Amphiphilic drugs also undergo 
pH, concentration and temperature dependent phase separation.*''^ It was 
further observed that CP can vary with additives."'"'^ Many pharmacologically 
active compounds are hydrophobic and cannot travel through the water based 
body systems. However, some drugs are amphiphilic in nature and may 
aggregate to form micelles.''^ Drug self-association depends on the drug 
structure, its concentration, pH, temperature and additive concentration.''*"'^ 
Aggregates of these amphiphilic drugs could act as their own carriers. It has 
been postulated that the drug vesicle formation is also feasible.'* However, 
most drugs are not lipophilic enough to form vesicles and hence require drug 
delivery systems to administer them into the body and to help control the site of 
delivery. For drug delivery it is essential that the drug carrier must not be 
mistaken for invading microbes otherwise they will rapidly be mopped up by 
microphages. Over the years, therefore, micelles have been of interest to 
pharmacological scientists either as drug delivery systems or as targeting 
systems.'^ Both cases have the advantage of protecting the body from side 
effects of the drug at the same time attaining the required concentration of the 
drug at the site. 
When using these drugs it should be kept in mind that normal human 
body temperature is typically 12 degrees above ambient. Even if the CP of a 
pure drug in buffer is above this temperature, it may decrease in presence of 
additives, especially with surfactants (which are used as drug carriers). 
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At CP the drug concentrates into a small volume, leading to localized 
high concentration at a particular site. This may lead to aggregation causing a 
change in biological activity due to decreased ability to pass through biological 
barrier and may prove harmful. 
Human blood plasma normally has a pH close to 7.40. Should the pH-
regulating mechanisms fail, as may happen in severe uncontrolled diabetes 
because of the acidosis caused by over production of metabolic acids, the pH of 
the blood can fall to 6.8 or below and can lead to irreparable damage and 
death.'^ *^  And in other diseases, the pH may rise to the point of no return. These 
observations indicate that pH effect should be taken into account when dealing 
with a drug solution. Investigations on the effect of additives and experimental 
pH on the clouding behaviour of amphiphilic drugs were started fairly 
recently. "^ "'^  In order to get insight of morphological aspects involved when a 
drug solution approaches the CP, clouding behaviour of amphiphilic drugs in 
aqueous buffer solutions was examined by investigating the following factors: 
(1) pH, (2) nature and concentration of externally added salts, (3) addition of 
ureas and thioureas, (4) addition of sugars, (5) addition of amino acids, (6) 
addition of alcohols, (7) addition of anionic, cationic (conventional and gemini) 
and nonionic surfactants, and (8) addition of polymers. 
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Results and Discussion 
Effect ofpH 
As we have mentioned before that the dnigs used in the present 
investigations can behave as cationic surfactant at pH<7, intermolecular and 
intermicellar interactions depend on the polar head charge and counterion 
concentration. Therefore, the clouding behaviour of amphiphilic drug solutions 
should be influenced both by pH and ionic strength. Indeed, maintaining the 
[drug] fixed (50 mM (or 100 mM for IMP) — all above the cmc of the drugs) 
and increasing the pH permitted us to observe the clouding phenomenon. The 
results plotted in Figs. 4.1 and 4.2 show that the CP decreases as the pH value 
of the drug solutions increases (whether or not an additive is present). In the pH 
range employed, this decrease in the CP implies a significant change in the 
micellar surface charge. Depending upon the solution pH, the hydrophilic tert-
amine of the drug molecule becomes protonated (i.e., cationic) or deprotonated 
(i.e., neutral). With the increase in solution pH, number of un-ionized 
(deprotonated) drug molecules in micelles increases. Thus the observed 
behaviour can be explained in terms of reduction of electrical repulsion due to 
increased fraction of the deprotonated drug with the concomitant enhancement 
in micellar aggregation number leading to decrease in the CPs. The behaviour 
remains same in the presence of additives also with a difference that the CP 
values (increase or decrease as compared to the no additive case) being 
dependent upon the nature of the additive. 
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Effect of electrolytes 
(i) inorganic salts 
Effect of inorganic counterions (F , CI and Br ) on the CP of drug 
solutions is shown in Figs. 4.3 and 4.4. Addition of electrolytes causes an 
increase in CP and the order of increase is NaF < NaCl < NaBr. As halide ions 
carry charge opposite to the drug micelles they should interact electrostatically 
with the micelles. The degree of counterion binding is known to affect the size 
and shape of the micelles. ' Fluoride ion binding to cationic head group is 
weak (as F is highly hydrated; crystal radius: 1.36 A and hydrated radius: 3.52 
A)^^ and, therefore, with NaF addition micelle shape/size changes slowly and 
CP increase is slow. In case of NaBr, Br binds strongly to the micelles and 
increases the size of micelles. However, as Br is also hydrated, although less 
than F (crystal radius: 1.95 A and hydrated radius: 3.30 A),^^ it increases 
micelle hydration as well as CP. The size of CI (crystal radius: 1.81 A and 
hydrated radius: 3.32 A)^^ is in between F and Br , hence CP increase is 
intermediate to F and Br . The CP increase with micellar growth has been 
proposed by Kim and Shah.'° They observed larger increase in CP as well as in 
UV-vis intensity of AMT drug solutions with the addition of NaBr as 
compared to NaF addition. 
Figs. 4.5 and 4.6 depict the variation of CP of drug solutions in presence 
of inorganic co-ions (Li"", Na"", K"^  and NH,""). The same CP increasing effect 
was found with MBr (M = Li, Na, K, or NH4). The order of CP increase is LiBr 
< NaBr < KBr < NHjBr. Ions can be classified into Hofmeister series 
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according to their hydrated radius and salting-out strength.'^ '^  Salts on the left 
hand side of the series are water-structure makers and decrease the solute 
solubility while salts on the right hand side are considered as water-structure 
breakers and increase the solute solubility in water.^ '^  Another mechanism for 
Hofmeister series behaviour relates salting-in and salting-out phenomena 
directly to adsorption or desorption of ions to the hydrophilic parts of the 
organic compounds.^^ In the series of MBr salts, Li"^  is highly hydrated (^ h = 
3.82 A) ^^  and would act as a water-structure promoter decreasing the 
availability of water to the micelles which resuhs in a slow increase in CP. Na"^ , 
K"^ , or NH4"^  are comparatively less hydrated (for Na"^ , r^ = 3.58 A, for K"^  and 
NH4^ /"h = 3.31 A/^ and result in increase in micelle hydration. Therefore, CP 
increases sharply. However, this trend changes with CPZ (i. e., KBr < NaBr < 
NKjBr <LiBr). The results cannot be explained at the moment; probably 
presence of CI in CPZ molecule is playing a role toward overall clouding 
behaviour of the drug in presence of these salts. 
(ii) quaternary ammonium bromides 
Figs. 4.7 and 4.8 show the variation of CP of 50 mM (lOOmM for IMP) 
of drug solutions prepared in 10 mM SP buffer (pH = 6.7) as a function of the 
concentration of added quaternary ammonium bromides (QABs). All the salts 
cause an increase in CP and the increase is in the order of 
TMeAB>TEtAB>TPrAB>TBuAB>TPeAB. The QABs are less hydrated than 
the inorganic salts. It was reported that the tetraalkylammonium ions are water-
structure formers and this effect increases with increase in the length of the 
alkyl group. The CP rising in the case of QA"^  cations is ascribed to 
adsorption/mixed micelle formation predominating over water structure 
formation. In such cases, micelles would experience greater intermiceliar 
repulsions and consequently higher CPs. This indeed has been observed 
experimentally (Figs. 4.7 and 4.8). 
Efeect of ureas and thioureas 
As shown in Figs. 4.9 and 4.10, all the ureas decrease the CP. It is well 
known that ureas decrease the polarity of micelles.'^ '^^ ^ Two different 
mechanisms have been proposed to explain the effect of urea on micellar 
systems: ^°'^' (i) urea affects only the solvent changing the water-structure and 
promoting the dissolution of the hydrophobic species (known as the indirect 
mechanism), and (ii) urea participates in the solvation of the hydrophobic 
species by replacing some water molecules in the hydration shell of the solute 
(known as the direct mechanism). The first mechanism is the most widely 
accepted one and urea is considered as water-structure breaker. ' However, 
Monte Carlo and molecular dynamics calculations suggest that there are very 
small differences between the properties of bulk and interfacial water, ' 
hence favouring the direct mechanism. Our results also support the direct 
mechanism. Urea replaces water from the head group region; therefore, CP 
decreases with urea addition. Briganti et al. ^'^ observed increase in surface area 
per head group for n-dodecylhexaethylene oxide-urea system. They suggested 
that the urea molecules replace some of the water molecules from the head 
group region of the micelles. 
I l l 
Rate of decrease in CP increases as the number of methyl groups 
increases in urea. Inclusion of mono-, di- and tetramethyl groups in urea 
increases the size of alkyl ureas and, therefore, more water is replaced by their 
addition with the result that the CP decrease becomes progressively more 
pronounced, i.e., TMU>DMU>MMU (Figs. 4.9 and 4.10). 
Effect of adding thioureas on the CP of the drugs is interesting — it's 
opposite to what has been observed with ureas in case of AMT and IMP (Fig. 
4.9) but same in case of CPZ and PMT (Fig. 4.10). The opposite effect of 
thiourea may be due to the difference in the nature of bonds: the >C=0 is 
stronger than >C=S as O is more electronegative. Therefore, electrons around S 
atom will be delocalized, thus making the S-atom electron deficient, i.e., a 
Lewis acid. As a result, the S-atom in thiourea would behave like a positive 
center"'^ '^ ^ and repulsion between thiourea and drug micelle (a cationic center) 
could be responsible for the observed CP increase. However, with 
phenothiazines, CP decrease may be due to presence of a S-atom in the drug 
molecules. 
Effect ofsusars 
The variation of CP of drug solutions as a function of added sugars is 
shown in Figs. 4.11 and 4.12. The addition of each of the compounds of this 
category produces a decrease in the CPs. These observations are similar in 
form to the decrease in the water solubility of hydrophobic derivatives caused 
by sugars and reinforce the belief that 'water-structure makers' strengthen the 
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hydrophobic interactions'*" by addition of water molecules through hydrogen 
bonding into flickering clusters shifting equilibrium 
nH20 ^ (H20)n 
toward the right side. The CP depression indicates a 'salting-out' effect because 
the temperature range in which single phase solutions prevail is reduced.^^ The 
sugars remove water molecules surrounding the micelle and help the micelles 
to approach each other easily. It was suggested by Kjellander and Florin'*' that 
appearance of cloud point is entropy dominated. When the additives (sugars) 
are added, the water of hydration of the micelles decreases, as these additives 
compete for water molecules associated with the micelle. Thus, with two 
relatively less hydrated micelles approaching each other, the hydration spheres 
overlap and some of the water molecules are set free to increase the entropy of 
the system. At cloud point, the water molecules get totally detached from the 
micelles. In any case, the overall entropy is high and hence the free energy 
change is relatively more negative and the appearance of CP is facile.'*^ 
Effect of amino acids 
Figs. 4.13 and 4.14 show the variation of CP of drug solutions with the 
addition of various amino acids. The initial pH of all the drug solutions was 
6.7. We can see that the acidic amino acids increase CP sharply, while non-
polar and uncharged polar amino acids are much less effective. The 
effectiveness depends on the nature and molecular structure of the amino acid. 
All a- amino acids have similar functional groups with different side chains. 
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Kabir-ud-Din et al/^ have shown that the rates of micellar mediated chemical 
reactions increase with an increase in the hydrophobicity of the amino acid side 
chain. The effect of amino acids on the CP may be explained on the basis of 
taking cognizance of polarity and hydrophobicity. In case of acidic amino acids 
(DL-aspartic and glutamic acids), the acidic group would interact with the 
tertiary amine of drug allowing entry of water and resulting in more hydrated 
micelles; this leads to increase in the CP. On the other hand, hydrophobic 
nonpolar and uncharged polar amino acids would prefer either the micelle 
interior or bulk water and in doing so they would not affect the hydration of 
micelles. Therefore, the latter category of the amino acids would not affect CP 
much, as indeed observed in Figs. 4.13 and 4.14. 
Figs. 4.15 and 4.16 show the effect of basic amino acids and their 
hydrochloride saUs on the CP. The basic amino acids (L-lysine, L-arginine and 
L-histidine) prefer a polar environment, and thus they would partition in the 
head group region. This partitioning would replace certain amount of water 
from the head group region with the observance of CP phenomenon at a lower 
temperature. This indeed is observed. In case of hydrochloride salt additions, 
however, a positive charge would be imparted to drug micelles with a 
concomitant repulsion among the aggregates and an increase in CP is observed. 
Effect of alcohols 
Figs. 4.17 and 4.18 show the effect of aliphatic alcohols on the CP of 50 
mM (150 mM for IMP) drug solutions. The CP remains constant with short 
chain alcohols while longer chain ones cause a decrease in CP. The medium 
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chain alcohols show a peaked behaviour. It is well known that addition of short 
and medium chain alcohols to aqueous surfactant solutions causes a decrease in 
micellar size whereas long chain alcohols increase micellar aggregation 
number.'*'*'^ ^ This difference in alcohol behaviour can be explained in terms of 
difference in solubilization site and mechanism of solubilization of the 
alcohols. Short chain alcohols are hydrophilic in nature and due to favourable 
interactions with water, these alcohols modify the water structure, making it 
more compatible with the single surfactant molecules.'*^ Medium chain length 
alcohols distribute between the two phases (distribution coefficients in the 
range 0.3-0.9'*^), whereas hydrophobic interactions that occur with longer chain 
alcohols favour the aggregation process and they do penetrate into the 
micelles."*^ At high concentrations, it has been proposed'*^ that medium chain 
alcohols also solubilize in micellar palisade layer and increase the aggregation 
number. 
While considering micelle formation in ionic amphiphiles, two factors 
should be kept in mind. First, the electrostatic repulsion among charged head 
groups which favours small micelles with high surface area per head group and 
second, the hydrophobic interactions among alkyl chains which favour large, 
tightly packed structures with small surface area per head group.^° Alcohols, as 
discussed above, depending upon their chain length and concentration, affect 
both of these factors. Short chain alcohols (up to C3OH), remain in aqueous 
phase and would not affect the micelle size/shape; hence CP remains constant. 
C4OH causes micelles to disintegrate leading to slow increase in CP. With the 
115 
addition of C5OH and CgOH, CP first increases (except PMT) up to certain 
concentration and then decreases. The peak position and decrease becoming 
prominent with the increase in chain length of the alcohol. These observations 
indicate that up to certain concentration, alcohols solubilize in aqueous phase 
causing breakdown of micelles and above it, these alcohols start solubilizing in 
micellar phase. However, due to hydrophobicity, C7OH and CsOH solubilize 
deeper in the micellar phase at all concentrations. These alcohols intercalate 
between the surfactant monomers with their alkyl chains penetrating towards 
the micellar interior and -OH group in the head group region. This 
intercalation lowers the surface charge density leading to micellar growth. It 
also affects the Mitchell-Ninham parameter, Rp (= v/aolj.^^ Penetration of alkyl 
chains increases the hydrophobic volume (v) and simultaneously decreases the 
cross-sectional area per monomer (Oo). The result is an increase both in Rp-
value and aggregation number of the drug-alcohol system; the latter causing a 
decrease in CP. Similar trend was observed by Kim and Shah for the 
amitriptyline-alcohol system. 
Results of Figs. 4.19 and 4.20 can be explained in the light of above 
discussion. With ethanediol and propanediol, CP remains constant. Diols, being 
highly miscible in water and hydrophilic (as they contains two -OH groups on 
hydrophilic ethane or propane molecules), remain in aqueous phase at all 
concentrations and would not affect the micelle hydration. However, 
cycloalkanols show different behaviour; with cyclopentanol, CP decreases 
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from the start while with cyclohexanol it shows a peaked behaviour, which 
becomes more pronounced with allylalcohoi. 
Cyclopentanol is sparingly soluble in water while cyclohexanol is 
slightly soluble (3.6%w/w). This shows that cyclopentanol is more 
hydrophobic than cyclohexanol. Therefore, cyclopentanol solubilizes in the 
micelles, which is evident from the decrease in CP from the start. 
Cyclohexanol, after 100 mM (except PMT), starts solubilizing in the micelles. 
Allyl alcohol is completely miscible with water. The decrease in CP in its 
presence can be explained in the light of its effect on solvent structure. It 
promotes the water structure thereby decreasing the availability of water to the 
micelles. 
Effect of surfactants 
(i) anionic surfactants 
Figs. 4.21 and 4.22 show the effect of anionic surfactants on the CP of 
50 mM (150 mM for IMP) drug solutions. In drug solutions, added anionic 
surfactants (SDS/SDBS) would behave as counterions to the drug micelles. 
Also, penetration of dodecyl/dodecylbenzene chain into the micelles is 
probable. These factors should decrease the CP. However, we observe a 
different behaviour with SDS/SDBS. As shown in Figs. 4.21 and 4.22, CP 
increases up to a certain surfactant concentration and then decreases. At low 
concentrations surfactant molecules adsorb at the micellar interface and inhibit 
micellization resulting in an increase in CP. At higher concentrations the added 
surfactant increases the compactness of the micelles and leads to micellar 
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growth. Intercalation of DS /DBS anions into the drug micelles would reduce 
the head group repulsions and enhance the hydrophobic interactions. This, in 
turn, would reduce QQ and increase v. Therefore, Rp increases with anionic 
surfactants. 
SDBS addition shows slight increase and a sharp decrease in CP which 
indicates that SDBS is more hydrophobic than SDS. A phenyl group is 
considered to be equivalent to three or four carbons in a straight chain. ^ ^ This is 
reflected in a lower cmc value for SDBS.^ "* As a resuh, greater hydrophobic 
interactions occur between the benzene ring of the SDBS monomer and the 
hydrophobic portion of the drug molecule. Also, the presence of a benzene ring 
causes greater electrostatic interaction with cationic drug molecules. All of 
these factors make SDBS more effective in dehydrating the drug micelles 
causing a sharper decrease in CP at higher relative concentrations. 
(ii) cationic surfactants 
Effects of cationic surfactants, conventional as well as geminis, on the 
CPs are shown in Figs. 4.23 and 4.24. The CP increases with addition of all the 
surfactants. The magnitude of CP increase is found to be dependent upon the 
chain length of the alkyl chain present in the conventional surfactant (CTAB or 
TTAB) with the longer chain lengths increasing the CP to a higher degree. The 
presence of a counter-ion (Br~) is responsible for the decrease in surface area 
occupied per drug head group, with a simultaneous increase in Rp.^ ^ An 
increase in Rp results in micellar growth. The added cationic surfactants exist in 
the drug solutions as monomers, micelles and mixed micelles depending on 
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their cmc values. Addition of CTAB, which forms larger micelles than TTAB, 
generates stronger electrostatic repulsion between micelles and produces a 
higher CP. 
The CP-[gemini] profiles (Figs. 4.23 and 4.24) illustrate that the cationic 
gemini surfactants show a stronger effect on CP increase in comparison to the 
conventional ones. Gemini surfactants are made of two hydrophobic chains and 
two polar head groups covalently attached through a spacer.^^ One outcome of 
the covalent spacer insertion between two N'*' centers at the level of head 
groups is the imposition of additional geometric constraint on the surfactant 
intra-molecular packing. This, in turn, influences the micellar morphology. 
Because spheroids and ellipsoids differ in terms of curvature,"'''' a larger 
effective charge would be expected for a spherical micelle compared to an 
ellipsoidal morphology. It was reported that micellar charge increases with 
increasing spacer chain length, although not monotonically."'^'^ In our CP 
results on the drug solutions, one can see that the role of spacer length is quite 
distinct. Therefore, both micellar morphology and charge play important roles 
in deciding the CP of the drug solutions. As mentioned earlier that if the 
surfactant is in monomeric form, it would form mixed micelles while cationic 
micelles of the surfactant would exist if the [surfactant] is above cmc. Both 
cases increase the inter-aggregate repulsion (as discussed for QABs) with an 
increase in the CP of the drug solutions (Figs. 4.23 and 4.24). 
(Hi) nonionic surfactants 
Data on CP variation of drug solutions in presence of various nonionic 
surfactants clearly illustrate that all the nonionic surfactants cause an increase 
in CP (Figs. 4.25 and 4.26). All these surfactants are containing oxyethylene 
chains. When the nonionic surfactant-drug mixed micelles are formed, they 
would contain relatively more hydrated water in comparison to that a micelle of 
pure drug. This increased water of hydration provided by oxyethylene chains 
seems the prime cause of CP increase of drug solutions. It can also be seen 
from figures that the CP increase is highest with TX-lOO and lowest with 
Tween 20. This may be due to the presence of unidentical as well as different 
number of hydrophobic and hydrophilic groups, which would affect the CP 
behaviour of drug solutions in a different manner. 
Effect of polvvinylpyrrolidones fPVP) 
We also investigated the effect of PVP polymers on the CP of drug 
solutions. Figs. 4.27 and 4.28 show the variation of CP of 50 mM of drug 
solutions prepared in 10 mM SP buffer (pH = 6.7). Considering the two 
extremes, i.e., the lowest and highest molecular weight polymers used, we see 
that the former first increased the CP (but slowly), followed by a rapid 
increase, whereas the latter only decreased the CP: others showing intermediate 
behaviour. Thus, the present data (shown in Figs. 4.27 and 4.28) suggest that 
the polymer size have a role to play in varying the CP of drug solutions. It 
seems that the polymers interact with the drug micelles and cause a variation in 
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water of hydration to different extent. However, the nature of correct 
interaction(s) between the drug and polymers is yet to be settled. 
Effect of additives at different fixed pHs 
Figs. 4.29 - 4.36 depict the variation of CP of 50 mM (100 mM in case 
of IMP) of the drug solutions at different fixed pHs prepared in 10 mM SP 
buffer. Additive concentration variations at different fixed pHs (all below pA^ a 
values of the drugs)^ show that increase/decrease in pH causes a 
decrease/increase in CP. With all the additives, the trend of CP variation 
remains exactly the same as observed at pH = 6.7 (for comparison, plots of pH 
= 6.7 are shown in Figs. 4.29-4.36). 
Effect of additives at different fixed drug concentrations 
Figs. A.?)1-AAA show the effect of additive concentrations on the CPs of 
drug solutions at different fixed concentrations, prepared in 10 mM sodium 
phosphate buffer (pH = 6.7). The trend of CP variafions with different additives 
is the same as described earlier. Increase in drug concentrations, however, 
increases the number of micelles (which are charged). This increased number 
of micelles increases the inter-micellar and intra-micellar repulsions and hence 
CP increases (Figs. 4.37-4.44). 
Effect ofpH variation at different fixed 16-6-16 semini concentrations 
Variation of CP with pH in the presence of different fixed 
concentrations of 16-6-16 (Figs. 4.45 and 4.46) show that the CP of the drug 
solutions increases with the concentration of the gemini surfactant and the 
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clouding region appears at a comparatively much higher temperature. This 
allows us to say that by judicious selection of the surfactant and its 
concentration, one can safely produce a 16-6-16-drug system, which can check 
the phenomenon of clouding and phase separation at body temperature and pH. 
Hence, for transporting drugs into human body, we need a surfactant system 
with the above two characteristics in addition to its body compatibility. 
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pH 
Fig. 4.1: Effect of pH on the CP of 50 mM AMT (A) and 100 mM IMP (B) 
solutions, prepared in 10 mM sodium phosphate buffer, containing no or a 
fixed additive concentration. 
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PH 
Fig. 4.2: Effect of pH on the CP of 50 mM CPZ (A) and 50 mM PMT (B) 
solutions, prepared in JO mM sodium phosphate buffer, containing no or a 
fixed additive concentration. 
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Fig. 4.3: Effect of anionic counterions on the CP of 50 mMAAfT (A) and 100 
mM IMP (B) solution, prepared in 10 mM sodium phosphate buffer (pH = 6.7), \ 
indicates precipitation occurring beyond [NaBr] >100 mM at room' 
temperature (which could be due to formation of nonmicellar phases). 
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Fig. 4.4: Effect of anionic counterions on the CP of 50 mM CPZ (A) and 50 
mM f'MT (B) solution, prepared in 10 mM sodium phosphate buffer (pH = 
6.7), I indicates precipitation occurring beyond [NaBr] >100 mM at room 
temperature (which could be due to formation of nonmicellar phases). 
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Fig. 4.5: Effect ofcationic colons on the CP of 50 mM AMT (A) and 100 mM 
IMP (B) solution, prepared in 10 mM sodium phosphate buffer (pH = 6.7). 
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Fig. 4.6: Effect of cationic colons on the CP of 50 mM CPZ (A) and 50 mM 
PhfT (D) solution, prepared in 10 mM sodium phosphate buffer (pH = 6.7). 
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Fig. 4.7: Effect of quaternary ammonium bromide salts concentration on the 
CP of 50 mM AMT (A) and 100 mM IMP (B) solution, prepared in 10 mM 
sodium phosphate buffer (pH = 6.7). 
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Fig. 4.8: Effect of quaternary ammonium bromide salts concentration on the 
CP of 50 mM CPZ (A) and 50 mM PMT (B) solution, prepared in 10 mM 
sodium phosphate buffer (pH = 6.7). 
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Fig. 4.13: Effect of amino acids concentration on the CP of 50 mM AMT (A) 
and 100 mM IMP (B) solution, prepared in 10 mM sodium phosphate buffer 
(pH = 6.7). 
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Fig. 4.19: Effect of amino acids concentration on the CP of 50 mM AAfT (A) 
and 150 mM IMP (B) solution, prepared in 10 mM sodium phosphate buffer 
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(A) and 150 mM IMP (B) solution, prepared in 10 mM sodium phosphate 
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Fig. 4.23: Effect of cationic surfactants concentration on the CP of 50 mM 
AMI (A) and 100 mM IMP (B) solution, prepared in 10 mM sodium phosphate 
buffer (pH = 6.7). 
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Fig. 4.25: Effect of cat ionic surfactants concentration on the CP of 50 mM 
AMT (A) and 100 mM IMP (B) solution, prepared in 10 mM sodium phosphate 
buffer (pH = 6.7). 
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Fig. 4.26: Effect of nonionic surfactants concentration on the CP of 50 mM 
CPZ (A) and 50 mM PMT (B) solution, prepared in 10 mM sodium phosphate 
buffer (pH = 6.7). 
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Fig. 4.28: Effect of polyvinylpyrrolidones concentration on the CP of 50 mM 
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Fig. 4.36: Effect of CTAB concentration on the CP of 50 mM CPZ (A) and 50 
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Fig. 4.42: Effect of n-hexanol concentration on the CP of different fixed 
concentrations (50 to 100 mM) ofCPZ (A) and PMT (B) solutions, prepared in 
10 mM sodium phosphate buffer (pH = 6.7). 
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Fig. 4.43: Effect of CTAB concentration on the CP of different fixed 
concentrations of AMT (A) and IMP (B) solutions, prepared in 10 mM sodium 
phosphate buffer (pH = 6.7). 
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Fig. 4.44: Effect of CTAB concentration on the CP of different fixed 
concentrations ofCPZ (A) and PMT (B) solutions, prepared in 10 mM sodium 
phosphate buffer (pH = 6.7). 
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Fig. 4.45: Effect ofpHon the CP of 50 mMAMT (A) and 100 mMIMP (B) in a 
10 mM sodium phosphate buffer solution containing different fixed 
concentrations of 16-6-16. 
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Fig. 4.46: Effect ofpH on the CP of 50 mM CPZ (A) and 50 mM PMT (B) in a 
10 mM sodium phosphate buffer solution containing different fixed 
concentrations of 16-6-16. 
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